Intellectual Property Law

Intellectual property law comprises a suite of legal rights—patents, trademarks, copyright and related rights, design rights and trade secrets—designed to reward creative and technical effort by granting creators and investors temporary exclusivity in return for public disclosure of their work. At the international level, the WTO’s TRIPS Agreement sets minimum standards for patent protection, data exclusivity and enforcement measures, while a network of WIPO-administered treaties and regional instruments harmonises formalities and facilitates multi-jurisdictional filings. National regimes implement these norms with varying thresholds for novelty, inventive step and distinctiveness, and employ tools such as compulsory licensing, parallel importation and patent linkage to balance private monopolies against health, competition and development objectives. Recent debates highlight the need to modernise IP frameworks for digital distribution, open-science collaborations and equitable access to medicines, reflecting tensions between proprietary incentives and the public interest in a global knowledge economy.

Research from Nature Portfolio

A recent proposal for “benevolent” patent extensions links additional exclusivity in high-income markets to commitments by innovators to invest in new vaccines, agricultural inputs or other socially beneficial technologies for low- and middle-income countries. Economic modelling suggests that tying extra patent term to targeted R&D funding could generate substantial resources for neglected areas without eroding core incentives for breakthrough discovery, reframing life-cycle management in a development-oriented context.

Work on material-transfer agreements introduces an “open” form of biological-materials licence that streamlines the sharing of cell lines, plasmids and other research reagents. By providing standardised, no-fee terms that govern downstream use and redistribution, this mechanism lowers administrative barriers to collaboration, accelerates pre-competitive discovery in biotech and ensures practical freedom to operate within prevailing technology-transfer realities.

Intellectual Property Law publication trend

The graph below shows the total number of articles in intellectual property law across all publications each year (not limited to Nature Index journals).

Technical terms

Patent term extension: A statutory prolongation of a patent’s monopoly beyond its standard term, often granted in exchange for regulatory or social-benefit commitments.

Data exclusivity: A period during which regulatory authorities will not rely on originator clinical trial data to approve generic or biosimilar versions of a drug.

Compulsory licensing: A government-ordered authorisation for third parties to use a patent without the patent holder’s consent, subject to payment of remuneration, typically invoked on public health grounds.

TRIPS flexibilities: Provisions in the WTO TRIPS Agreement that permit measures such as parallel importation and compulsory licensing to address domestic policy objectives.

Material-transfer agreement: A legal contract governing the transfer, use and redistribution of research materials (cells, plasmids, reagents) between institutions under standardised terms.

References

1. ‘Benevolent’ patent extensions could raise billions for R&D in poorer countries. Nature (2023).
2. Opening options for material transfer. Nature Biotechnology (2018).
3. What is the impact of intellectual property rules on access to medicines? A systematic review. Globalization and Health (2022).
4. Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act. PLOS Medicine (2024).
5. Financing constraints, intellectual property rights protection and incremental innovation: Evidence from transition economy firms. Technological Forecasting and Social Change (2024).
6. Intellectual Property Law.